chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore Neck  after 2nd booster; Swelled up from left Ear to left Shoulder  after 2nd booster/Entire left arm swelled up after 2nd booster; Like I had a flu after 2nd booster; Red entire left arm  after 2nd booster; Sore Arm  after 2nd booster; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Sore Neck  after 2nd booster), PERIPHERAL SWELLING (Swelled up from left Ear to left Shoulder  after 2nd booster/Entire left arm swelled up after 2nd booster), INFLUENZA LIKE ILLNESS (Like I had a flu after 2nd booster), ERYTHEMA (Red entire left arm  after 2nd booster) and PAIN IN EXTREMITY (Sore Arm  after 2nd booster) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M21A, 014F21A, 012M20A and 011L210A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2022, the patient experienced NECK PAIN (Sore Neck  after 2nd booster), PERIPHERAL SWELLING (Swelled up from left Ear to left Shoulder  after 2nd booster/Entire left arm swelled up after 2nd booster), INFLUENZA LIKE ILLNESS (Like I had a flu after 2nd booster), ERYTHEMA (Red entire left arm  after 2nd booster) and PAIN IN EXTREMITY (Sore Arm  after 2nd booster). On 10-Apr-2022, PERIPHERAL SWELLING (Swelled up from left Ear to left Shoulder  after 2nd booster/Entire left arm swelled up after 2nd booster), INFLUENZA LIKE ILLNESS (Like I had a flu after 2nd booster) and ERYTHEMA (Red entire left arm  after 2nd booster) had resolved. At the time of the report, NECK PAIN (Sore Neck  after 2nd booster) and PAIN IN EXTREMITY (Sore Arm  after 2nd booster) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment medication was not taken.   This case was linked to MOD-2022-538188 (Patient Link).
Vaccine received 9/21/09 without incident. Today (9/24/09) sudden onset pain and numbness- mostly resolved x 1 hour later.
Patient experienced muscle soreness at the site of the injection starting 1 day after the shot was given in the left deltoid. She also experienced "great weakness, exhaustion, and chills", all of which subsided 1-2 days after symptom onset.
breakthrough covid infection 30Aug2021; breakthrough covid infection 30Aug2021; This is a spontaneous report from an other health care professional (patient). This 61-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) 1st dose 03Mar2021 13:00, 2nd dose on 24Mar2021 13:00, both at single dose via an unknown route in left arm at 60-year-old for Covid-19 immunization. Medial history included known allergies with PCN, aspirin, ibuprofen. Patient had no Covid prior vaccination. No other medical history. Concomitant drug was not provided.  No other vaccine in four weeks. No other medications in two weeks. Patient experienced adverse event of breakthrough covid infection on 30Aug2021. The adverse event start on 29Aug2021. Nasal Swab PCR Covid test post vaccination on 30Aug2021 was positive. The event resulted in Doctor or other healthcare professional office/clinic visit. No treatment received for the event. Outcome of the event was not resolved.    The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported vaccination failure / COVID-19 cannot be ruled out.
pt recvd vax;c/o stomachache;to bed,was fine at that time;during noc,pt seemed restless,was feverish;gave apap at 5am;pt became nauseated then rigid,eyes rolled back,non responsive for approx 3min;to hosp;c/o headache when responsive;tx adv
flu-like symptoms; lethargy; lingering pain in left arm pit lymph node; Soreness at injection site; fever/chills; fever/chills; whole body muscle/joint aches; whole body muscle/joint aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Nov2022 at 19:00 as dose 4 (booster), single (Lot number: GJ6665) at the age of 44 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: FLU [INFLUENZA VACCINE] taken for immunisation, on 28Oct2022 as dose 1, single; TDAP taken for immunisation, on 28Oct2022 as dose 1, single; SYNTHROID; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; MIDNITE; AIRBORNE. Past drug history included: Neosporin, reaction(s): "known allergies: Neosporin"; Possibly aspirin, reaction(s): "Known allergies: possibly aspirin". Vaccination history included: Bnt162b2 (DOSE 1), for COVID-19 Immunization; Bnt162b2 (DOSE 2), for COVID-19 Immunization, reaction(s): "Joint pain", "Tiredness", "Headache", "Migraine", "Stiff neck", "Shaky feelings", "Ache", "Vomiting"; Bnt162b2 (DOSE 3 (BOOSTER)), for COVID-19 Immunization, reaction(s): "Arthralgia", "Back pain", "COVID-19", "Chills", "Exposure to SARS-CoV-2", "Hyperhidrosis", "Hypoaesthesia", "Lymph node pain", "Lymphadenopathy", "Pain", "Vaccination failure". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Nov2022 at 06:00, outcome "recovering", described as "Soreness at injection site"; CHILLS (non-serious), PYREXIA (non-serious) all with onset 05Nov2022 at 06:00, outcome "recovering" and all described as "fever/chills"; INFLUENZA LIKE ILLNESS (non-serious) with onset 05Nov2022 at 06:00, outcome "recovering", described as "flu-like symptoms"; LETHARGY (non-serious) with onset 05Nov2022 at 06:00, outcome "recovering"; LYMPH NODE PAIN (non-serious) with onset 05Nov2022 at 06:00, outcome "recovering", described as "lingering pain in left arm pit lymph node"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 05Nov2022 at 06:00, outcome "recovering" and all described as "whole body muscle/joint aches". Therapeutic measures were taken as a result of influenza like illness, lethargy, lymph node pain, vaccination site pain, chills, pyrexia, myalgia, arthralgia.  Additional information: Zero prior events (four Pfizer shots). Soreness at injection site and flu-like symptoms (whole body muscle/joint aches, lethargy, fever/chills) resolved by Tylenol, lingering pain in left arm pit lymph node. Tylenol rapid release every 6-8 hours. Covid was not tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Patient indicated she immediately experienced flushed cheeks that persisted for approx 1 hour post vaccination. She also noticed worsening of asthma symptoms almsot immediately. The asthma symptoms persisted fro approx 3 days post vaccine & were somewhat improved wit horal Benadryl.
Pt c/o of pain in (L) arm w/movement/activity 11/25-11/29 developed rash which progressed over 2 days. Pt was seen at care center and Dx w/shingles rash. Rash progressed and (L) hand painful. Rx Acyclovir 400mg TID x 7 days.
I woke up with slightly itchy, severe skin rash on 2/23/2021 following second vaccine injection at 10:58 am on 2/21/2021. The rash completely covered both buttocks, the  top front inside of both thighs, both hips, the front groin area, inside/bottom of both feet. Given the extent and intensity of rash, it must have started on Monday 2/22/2021. The rash was red-purple with white spots (perhaps hives).   I contacted my primary care physician's office on 2/23/2021 and had a televisit with the nurse. Her diagnosis was Allergic Dermatitis/Itching. She prescribed Banophen (50 mg), Triamcinolone cream, and Cetirizine HCL (10 mg). I took the medicine.  Continued below.
This is in follow-up to report (s) previously submitted on 5/14/2007. Information has been received from a physician concerning a 11 year old female who on 15-MAR-2007 was vaccinated with GARDASIL (lot # 655619/1427F). On 09-APR-2007 the patient experienced a erythematous rash that spread from the injection site down one arm and then to the other arm. Medical attention was sought. The patient had unspecified blood work and had throat culture (results not reported). Subsequently, the patient recovered from rash. Additional information has been requested.
(L) arm red and painful, fever 102, aches, malaise. To MD on 10-23-10 order to cont. warm compresses. Return to MD 10-25-10 Tx with KEFLEX and IM inj. of ABT.
About 15mins after the injection I experienced a fast heart rate.  139bpm. My heart rate went down to 115ish but lasted for 3 days. I monitored myself. I did not recieve medical attention.  I don't not have a primary care doctor at this time. I would have contacted them. I have a pulse program on my phone for documentation.
Patient states that on the evening of the 23rd her left arm started hurting, she had flushing, itching, and throat swelling.
I had mild cold-like symptoms. It was so mild that the only reason I tested myself was because my daughter tested positive for COVID-19 around 12/20/2022. I had a cough, slight headache, and slight fatigue. I didn't contact my doctor because I already had an appointment about a week later. By then, my symptoms had subsided by taking over-the-counter medicine for recovery. Since then, I've been fine with no residual symptoms.
Vaccination given 6/5/19. On 6/7/19 a large area on the arm developed a rash that was red, warm, & tender. On 6/8/19 patient saw provider at the clinic, and was started on Cephalexin 500mg TID for 7 days. On 6/19/19 all signs of the reactions were gone,
Discharge Provider: MD Primary Care Provider:  MD Admission Date: 9/13/2022 Discharge Date: Sep 15, 2022  PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: patient presented with shortness of breath after being diagnosed with COVID six days prior; he was found to be weak so was admitted for this. patient had a cough, nausea, vomiting, and hiccups as well. he was treated conservatively and PT/OT as well as SLP were asked to see him. SLP recommended GI evaluation as patient c/o of food being regurgitated or sticking in his chest; esophogram was normal and GI signed-off recommending PRN follow-up. patient's hiccups improved with thorazine and after a d/w pharmacy protonix was added (to be taken for 30 days) as an adjunct to treat said hiccups. patient had a bit of an AKI (he has a solitary kidney and CKD with baseline of 2.2) which improved with IVF. d-dimer elevation attributed to COVID as his symptoms improved without VTE intervention and a BLLE venous doppler was negative. patient was amenable for discharge citing that he felt less short of breath, was coughing less, and had less hiccups. he was still feeling a bit weak. all questions and concerns addressed, all meds and follow-ups reviewed.
A pharmacist reported that a female received Hib-Titer vaccine at the ages of 2, 5 and 6 months. On 11/23/00, the pt (then 10 months of age) was hospitalized. A dx of haemophilus B influenza was made. She was treated with ceftriaxone. The lot number for the 1st dose of Hib-Titer administered on 3/13/00 was reported as 560906; however, this is not a valid Lederle lot number. Follow-up information received on 12/22/00, indicated that the pt was hospitalized for 10 days. Further follow-up received on 05/17/2001 indicated that the pt recovered.
Shot was extremely painful going in. By that night I had a raging headache. By the next morning my headache was worse. My arm where the shot was administered was extremely painful, very red, swollen and painful to the touch. I was nauseated, had diarrhea, and very fatigued. All these symptoms continued to get worse over the course of 4 days. By the 5th day after the shot, I finally started getting some relief. EXTREMELY concerned about going back in for the follow up injection!!
About 12 hours after injection, I woke up with nausea; About 12 hours after injection, I woke up with vomitting; About 12 hours after injection, I woke up with chills; Headache; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 14Apr2021 at 12:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high/taking meds for this. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN) and clonidine (MANUFACTURER UNKNOWN), both from unknown dates for unknown indications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 24Mar2021 at 12:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 00:00, the patient experienced woke up with nausea and vomiting, chills, headache and sore muscles. This lasted the better part of night with headache and sore muscles lasting longer. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea and vomiting, chills resolved on an unknown date in Apr 2021; while that of the events headache and sore muscles recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
PLEASE NOTE.  I AM THE PATIENT'S WIFE REPORTING THIS.  I DO NOT KNOW THE MANUFACTURER SO I JUST CHOSE ONE IN ORDER TO BE ABLE TO SUBMIT THIS REPORT.  This facility administered a 3rd PPV despite us telling them that we had previous ones in 2002, and 1997.  We were unable to read the PPV sheet as by the time it was given to us and the time we entered to have the vaccine, there was not enough time for us to thoroughly read and understand the sheet. Within 15 hours after vaccination, patient became very sick running a temperature of 100.2 to 101.8 for the next 72 hours with rigors and severe headache, along with aching and malaise all over.  Fever subsided finally, but administration site is still swollen, tender, and red.
Pt was given 2 month vaccines on 10/3/06 then 4 months given on 10/25/2006.
12 hours after vaccine had expected headache, aches, pains and fever 100.2 which last 48 hours but developed residual shortness of breathe with exertion and at night.  FOur days later symptoms of headache resturn but worsening SOB on exterion and night sweats.  COVID tested negative several times. No diarhea and no one ill at time at home.   Symptoms persisted now for one past vaccine admin, went to Urgent care.  COvid PCR negative and FLu negative.  d dimer normal , CRP sligh;lty elevated.  I was in atrial fibrillation.  I was unable to me medically converted to normal sinus over the next 48 hours and got electro cardio converted  successfully on September 22.  Echo showed no clots.
Nurse called out for emergency and second nurse gave BOOSTRIX that was handed to her instead of DTaP.
Initial report received from a health care professional on 11 October 2010. A 20-year-old male patient received on 11 October 2010 a right arm injection of FLUZONE SV 2010-2011, lot number U3655AA. Immediately after the vaccination on 11 October 2010, the patient fainted. He was treated with epinephrine 0.25 milligrams (mg) and was "revived". When he was sat up, he fainted again. The patient's heart rate was fluctuating between 45 - 90. He was taken by Emergency Medical Technician's (EMT's) to the hospital and was admitted. The outcome was reported as unknown. Documents held by sender: None.
redness 2ml diameter, Rx given 4/26/19 @ 1314pm Benadryl 12.5mg/5ml 5ml TID prn #120ml
CVS; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old male patient received BNT162b2 (BNT162B2), on 06Jan2022 as dose 1, single (Lot number: F13198) at the age of 26 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CYCLIC VOMITING SYNDROME (non-serious) with onset 2022, outcome "unknown", described as "CVS".  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.
The child received vaccine at 17:30. Mom then found child at 23:15 screaming with a temperature of 105F and convulsing. She placed the child in the bathtub and then brought to ER. The pt was treated with ibuprofen. Mom reports symptoms of irritability, ataxia and weakness for 5 days. She says the physician determined it to be a febrile seizure related to the vaccine. The pt had a reaction of fever and hives to DTAP/COMVAX/PREVNAR at 1.25 years of age.
This is a spontaneous report from a non-contactable pharmacist.  A female patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration, in the left arm, on an unspecified date, as single dose for immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced ocular flashes in eyes, twitches in neck area and headaches.  Clinical details were reported as follows:  The patient received the vaccination and within the same side the patient started getting ocular flashes in the eyes.  The patient also had headaches on the left side.  The outcome of ocular flashes in eyes, twitches in neck area and headaches was unknown. No follow-up attempts are possible. No further information is expected.
Patient experienced arm soreness, as the day went on experienced chills, fever of 99-100, body aches.
About 3 weeks after the first shot I noticed my hairbrush had more hair in it than usual.  So every morning I would gently comb my medium length hair very carefully and many hairs would come out of my head.  Then I got the second Moderna shot on April15, 2021.  It got worse.  I started saving the hair.  I am so scared that I will end up bald.  Some places 5 - 6, or more, hairs come out of each area at the same time.  All over my head it comes out.  I have always had nice hair and this has left me devastated.  When it began falling out I tried everything.  Women's vitamins, biotin for hair, vinegar for a hair rinse, plus many more.  With Mom and friends, we have come to the conclusion that getting the COVID shots has triggered something for me to lose my hair.  I have not changed eating habits nor medications.  Please help me.
This spontaneous pregnancy report as received from a registered nurse refers to a 28 year old female patient. The patient's medical history and current condition are not reported. On 11-JUN-2014 the patient was vaccinated with (Oka/Merck) VARIVAX (lot # J003219 and expiry date: 15-MAY-2015) of dose 0.5 ml, subcutaneous. Also vaccinated with M-M-R II (lot # J015503 and expiry date 05-DEC-2015) of dose 0.5 ml, subcutaneous on the same day. The patient became pregnant. A pregnancy urine test done on 21-JUN-2014 confirmed that the patient was pregnant. The last menstrual period and estimated date of conception are not reported. No adverse event is reported. Cancer and overdose are not reported. It was reported that the patient sought medical attention and contacted physicians office. Product quality issue was not reported. The outcome of drug exposure during pregnancy is unknown. Additional information has been requested.
Breast/armpit tenderness, lymph node swelling moderate side effect 5 out of ten.
I had left side chest pain and reflux. Numbness down the left arm.  Midcalf numbness and purpling of my foot through my ankle and all my toes. My doctor recommended to monitor it. By the morning it improved and I still just had the reflux and minor headache.
This spontaneous report was received from a healthcare worker refers to an unspecified patients of unknown age. On an unknown date, the patients were vaccinated with VARIVAX lot #L019999, 02-Jun-2017. 8 doses were administered. Temperature of 32.9F for 6 hours and 30 minutes. There were no previous excursion. This is one of the 2 cases received from the same reporter. Additional information has been requested.
Intense pain when moving arm for 18 days after immunization that continues today. Hurts to lift arm in any direction.
Patient called today to say that she developed hives about 2 hours after her vaccination yesterday.  (this was her 3rd dose  due to being immunocompromised)  She reports no reactions after her 1st and 2nd doses.  The hives are on both legs, her belly, under her breasts, and arms.  They are very itching and increased in number overnight.  No other symptoms reported.